Physician profile

Robin E Medic

Physical Medicine & Rehabilitation · Prince Frederick, MD

NPI 1821132234

$8,160.50

in general payments reported to CMS, 2019-2025

42 companies · $1,899 in 2025

The $1,899 reported for 2025 was more than what 93% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$4,677.68

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Boston Scientific Corporation $1,621.63 2022-2025 Wavewriter Alpha Prime 16, General - Pain Management
Abbvie INC. $1,556.65 2021-2025
Scilex Pharmaceuticals INC. $1,008.00 2019-2025 Ztlido
Pfizer INC. $636.88 2019-2025
Collegium Pharmaceutical, INC. $375.14 2019-2024 Xtampza, Belbuca
Biohaven Pharmaceutical Holding Company LTD. $336.79 2022
Allergan, INC. $269.18 2019-2022
Medtronic, INC. $261.48 2023-2025 Intellis Adaptivestim, Inceptiv
Nevro Corp. $255.47 2022-2024 Senza
Horizon Therapeutics Plc $222.42 2019-2022
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $191.91 2019-2022
Redhill Biopharma INC. $182.11 2020-2022
Biohaven Pharmaceuticals, INC. $126.74 2021
Electronic Waveform Lab, INC. $119.51 2022
Daiichi Sankyo INC. $108.08 2019
Show all 42 companies
CompanyGeneral paymentsYearsTop products
Biodelivery Sciences International, INC. $106.37 2019-2021
Arbor Pharmaceuticals, INC. $79.54 2019-2021
Globus Medical, INC. $67.89 2025 Senza
Pacira Therapeutics, INC. $57.78 2019
Zyla Life Sciences, INC. $50.75 2019
Abbott Laboratories $48.57 2025 Proclaim, Eterna
Hikma Pharmaceuticals USA $42.00 2022
Mdd US Operations, LLC $38.87 2019-2020
Lilly USA, LLC $36.73 2019-2021
Shionogi INC $36.60 2019
Medtronic USA, INC. $36.12 2019-2020
International Rehabilitative Sciences, INC $28.11 2024 Rs 4i Plus Sequential Stimulator
Saluda Medical Americas, INC. $27.14 2025 Evoke
Takeda Pharmaceuticals U.S.A., INC. $23.93 2019
Grt US Holding, INC. $22.67 2022
Tactile Systems Technology INC $19.19 2025 Flexitouch Plus, Nimbl
Vertos Medical, INC. $19.07 2021
Vertex Pharmaceuticals Incorporated $18.69 2025
Averitas Pharma INC. $18.59 2023 Qutenza
Teva Pharmaceuticals USA, INC. $18.51 2021
Spinal Simplicity, LLC $14.82 2025 Ha Minuteman G3-R
Assertio Therapeutics, INC. $14.58 2019
Curonix LLC $14.26 2025 Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A
Astrazeneca Pharmaceuticals LP $12.83 2019
Impel Pharmaceuticals INC. $12.16 2022
Vertical Pharmaceuticals, LLC $11.63 2019
Ultragenyx Pharmaceutical INC. $11.11 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Robin E Medic

$8,160.50

in general payments reported 2019-2025

Years
2019-2025
Top company
Boston Scientific Corporation
Context
The $1,899 reported for 2025 was more than what 93% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).

https://glasscript.com/doctor/264974/robin-e-medic

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.